SCOR SE Act. Prov. Regpt.
SCR: XPAR (FRA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| &H | LOCK|fn | LOCK|x<R&Y@ |
Scor Earnings: Some Lingering Effects in Life and Health Spook the Market
Scor has delivered a pretty decent set of results for the second quarter of 2025, beating company-compiled consensus in some key areas. However, we think the market is probably focused on some residual life and health negative experience variance.
